Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunopathogenesis and therapy of cutaneous T cell lymphoma
E. J. Kim
Journal of Clinical Investigation (2005) Vol. 115, Iss. 4, pp. 798-812
Open Access | Times Cited: 148

Showing 26-50 of 148 citing articles:

Cutaneous epitheliotropic T‐cell lymphoma in the cat: a review of the literature and five new cases
Jacques Fontaine, Marianne Heimann, Michael Day
Veterinary Dermatology (2011) Vol. 22, Iss. 5, pp. 454-461
Closed Access | Times Cited: 55
The Role of Systemic Retinoids in the Treatment of Cutaneous T-Cell Lymphoma
Auris Huen, Ellen J. Kim
Dermatologic Clinics (2015) Vol. 33, Iss. 4, pp. 715-729
Open Access | Times Cited: 47
Cutaneous T-cell lymphoma (CTCL): Current practices in blood assessment and the utility of T-cell receptor (TCR)-Vβ chain restriction
Juliet Fraser Gibson, Jing Huang, Kristina J. Liu, et al.
Journal of the American Academy of Dermatology (2016) Vol. 74, Iss. 5, pp. 870-877
Open Access | Times Cited: 41
Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets
Ieva Saulīte, Wolfram Hoetzenecker, Stephan Weidinger, et al.
BioMed Research International (2016) Vol. 2016, pp. 1-15
Open Access | Times Cited: 40
The role of NF‐κB in lymphoid malignancies
Graham Packham
British Journal of Haematology (2008) Vol. 143, Iss. 1, pp. 3-15
Closed Access | Times Cited: 56
Multicenter Photopheresis Intervention Trial in Early-Stage Mycosis Fungoides
Rakhshandra Talpur, M. Demierre, Larisa J. Geskin, et al.
Clinical Lymphoma Myeloma & Leukemia (2011) Vol. 11, Iss. 2, pp. 219-227
Closed Access | Times Cited: 47
STAT3 knockdown by siRNA induces apoptosis in human cutaneous T-cell lymphoma line Hut78 via downregulation of Bcl-xL
Navin Kumar Verma, Anthony M. Davies, Aideen Long, et al.
Cellular & Molecular Biology Letters (2010) Vol. 15, Iss. 2
Open Access | Times Cited: 46
Lymphoproliferative Disorders Associated With Hypereosinophilia
Florence Roufosse, Soizic Garaud, Laurence de Leval
Seminars in Hematology (2012) Vol. 49, Iss. 2, pp. 138-148
Closed Access | Times Cited: 41
Human Anti-CCR4 Minibody Gene Transfer for the Treatment of Cutaneous T-Cell Lymphoma
Thomas Han, Ussama M. Abdel‐Motal, De-Kuan Chang, et al.
PLoS ONE (2012) Vol. 7, Iss. 9, pp. e44455-e44455
Open Access | Times Cited: 40
Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma
Elisabetta Capriotti, Eric C. Vonderheid, Christopher J. Thoburn, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2008) Vol. 49, Iss. 6, pp. 1190-1201
Open Access | Times Cited: 47
High Clinical Response Rate of S ézary Syndrome to Immunomodulatory Therapies
Brian A. Raphael, Daniel B. Shin, Karen Rebecca Suchin, et al.
Archives of Dermatology (2011) Vol. 147, Iss. 12, pp. 1410-1410
Open Access | Times Cited: 39
TG1042 (Adenovirus-interferon-γ) in Primary Cutaneous B-cell Lymphomas: A Phase II Clinical Trial
Brigitte Dréno, Mirjana Urosevic‐Maiwald, Hyun Soo Kim, et al.
PLoS ONE (2014) Vol. 9, Iss. 2, pp. e83670-e83670
Open Access | Times Cited: 30
Novel therapies for cutaneous T-cell lymphoma: what does the future hold?
Emmanuella Guenova, Wolfram Hoetzenecker, Sima Rozati, et al.
Expert Opinion on Investigational Drugs (2014) Vol. 23, Iss. 4, pp. 457-467
Closed Access | Times Cited: 30
Total skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndrome
Camille E. Introcaso, Bizhan Micaily, Stephen K. Richardson, et al.
Journal of the American Academy of Dermatology (2008) Vol. 58, Iss. 4, pp. 592-595
Closed Access | Times Cited: 38
Cutaneous T-cell Lymphoma
Frederick Lansigan, Jaehyuk Choi, Francine M. Foss
Hematology/Oncology Clinics of North America (2008) Vol. 22, Iss. 5, pp. 979-996
Closed Access | Times Cited: 37
The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indications
Ercole Mazzeo, Laura Rubino, Michela Buglione, et al.
Reports of Practical Oncology & Radiotherapy (2013) Vol. 19, Iss. 2, pp. 77-91
Open Access | Times Cited: 29
CCR4 + T cell recruitment to the skin in mycosis fungoides: potential contributions by thymic stromal lymphopoietin and interleukin-16
Marina Tuzova, Jillian M. Richmond, Deon Wolpowitz, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2014) Vol. 56, Iss. 2, pp. 440-449
Closed Access | Times Cited: 28
Toll-like receptors in lymphoid malignancies: Double-edged sword
Sara Harsini, Maani Beigy, Mahsa Akhavan Sabagh, et al.
Critical Reviews in Oncology/Hematology (2013) Vol. 89, Iss. 2, pp. 262-283
Closed Access | Times Cited: 27
Vitamin D Deficiency in Mycosis Fungoides and Sézary Syndrome Patients Is Similar to Other Cancer Patients
Rakhshandra Talpur, Katherine M. Cox, Mimi I. Hu, et al.
Clinical Lymphoma Myeloma & Leukemia (2014) Vol. 14, Iss. 6, pp. 518-524
Closed Access | Times Cited: 26
CD164 identifies CD4+ T cells highly expressing genes associated with malignancy in Sézary syndrome: the Sézary signature genes, FCRL3, Tox, and miR-214
Bernice M. Benoit, Neha Jariwala, Geraldine M. O’Connor, et al.
Archives of Dermatological Research (2016) Vol. 309, Iss. 1, pp. 11-19
Open Access | Times Cited: 24
Stem cell transplantation in advanced cutaneous T-cell lymphoma
Camille E. Introcaso, Brian Leber, Kathleen Greene, et al.
Journal of the American Academy of Dermatology (2008) Vol. 58, Iss. 4, pp. 645-649
Closed Access | Times Cited: 34
A novel regimen of vorinostat with interferon gamma for refractory Sézary syndrome
Jennifer M. Gardner, Camille E. Introcaso, Sunita D. Nasta, et al.
Journal of the American Academy of Dermatology (2009) Vol. 61, Iss. 1, pp. 112-116
Closed Access | Times Cited: 28
Indolent CD8‐positive T‐cell lymphoid proliferation of the ear: a report of two cases
Weifen Zeng, Victor E. Nava, Philip L. Cohen, et al.
Journal of Cutaneous Pathology (2012) Vol. 39, Iss. 7, pp. 696-700
Closed Access | Times Cited: 26
Vascular endothelial growth factor receptor-3 expression in mycosis fungoides
Ida Holst Pedersen, Andreas Willerslev-Olsen, Claudia S. Vetter‐Kauczok, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2012) Vol. 54, Iss. 4, pp. 819-826
Closed Access | Times Cited: 25
A novel targeted immunotherapy for CTCL is on its way: Anti-KIR3DL2 mAb IPH4102 is potent and safe in non-clinical studies
Hélène Sicard, Cécile Bonnafous, Ariane Morel, et al.
OncoImmunology (2015) Vol. 4, Iss. 9, pp. e1022306-e1022306
Open Access | Times Cited: 22

Scroll to top